Effect of glargine addition to NPH or premixed insulin on glycaemic control in patients with type 2 diabetes / Eleanor A. Paculan-Luna ; Cynthia Chua-Ho ; Maellen Grace S. Alferos.
Language: English Publication details: Fairview, Quezon City Department of Medicine, FEU-NRMF, 2004Description: illustrations; (in folder)Content type:- text
- unmediated
- volume
- MED20040002
Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
Research | Far Eastern University - Nicanor Reyes Medical Foundation Research | MED20040002 (Browse shelf(Opens below)) | Available | R000111 |
Browsing Far Eastern University - Nicanor Reyes Medical Foundation shelves, Shelving location: Research Close shelf browser (Hides shelf browser)
Includes appendices and bibliographical references.
ABSTRACT: Insulin Glargine is a novel recombinant analogue of human insulin with a shift in the isoelectric point producing a retarded absorption rate and an increased duration of action that closely mimies normal basal insulin secretion. Insulin treatment can improve and maintain glycaemic control, preventing long term complications in type 2 diabetes.
Research - Department of Medicine
There are no comments on this title.